Skip to content

Semaglutide studies: 1,194 papers with results

Page 16 of 24

  1. Case report: Nerve fiber regeneration in children with melanocortin 4 receptor gene mutation related obesity treated with semaglutide.

    Gad H · Frontiers in endocrinology · 2024

    Case report or series · 6 results

  2. Lithium Toxicity and Altered Clearance Following Initiation of Semaglutide in Patients With Bipolar Disorder: A Case Series and Literature Review.

    Al-Soleiti M · Journal of clinical psychopharmacology · 2025

    Case report or series · 2 results

  3. Efficacy of Semaglutide in Pediatric Patients With Bardet-Biedl Syndrome and Alström Syndrome.

    Dauleh H · JCEM case reports · 2025

    Case report or series · 1 result

  4. Treatment Approaches for Obesity in Children With Heterozygous MC4R Variants.

    Salama M · Clinical obesity · 2026

    Case report or series · 1 result

  5. Great Expectations: Semaglutide as Antidiabetic Weight Management in a Psychiatric Hospital.

    Shannon K · Journal of pharmacy practice · 2025

    Case report or series · 2 results

  6. Effects of Semaglutide on Weight and Insulin Requirements in Two Adolescents With Type 1 Diabetes.

    Schwarz CR · Pediatrics · 2026

    Case report or series · 4 results

  7. Optic disc edema during semaglutide therapy: case report and literature review.

    Yang T · American journal of ophthalmology case reports · 2025

    Case report or series · 9 results

  8. Ketotic Hypoglycaemia Following Sleeve Gastrectomy.

    He J · Clinical endocrinology · 2025

    Case report or series · 1 result

  9. Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report.

    Klein SR · Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023

    Case report or series · 2 results

  10. Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report.

    Gulak MA · Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023

    Case report or series · 1 result

  11. Anesthesia Considerations for a Patient on Semaglutide and Delayed Gastric Emptying.

    Fujino E · Cureus · 2023

    Case report or series · 1 result

  12. Semaglutide in Cystic Fibrosis-Related Diabetes.

    Gnanapragasam H · The Journal of clinical endocrinology and metabolism · 2020

    Case report or series · 3 results

  13. Tendency of Semaglutide to Induce Gastroparesis: A Case Report.

    Chaudhry A · Cureus · 2024

    Case report or series · 1 result

  14. Risk of pulmonary aspiration during semaglutide use and anesthesia in a fasting patient: a case report with tomographic evidence.

    Queiroz VNF · Einstein (Sao Paulo, Brazil) · 2023

    Case report or series · 1 result

  15. Acute Pancreatitis in a Patient Taking Semaglutide.

    Patel F · Cureus · 2023

    Case report or series · 1 result

  16. Semaglutide for Treating Obesity Induced by Craniopharyngioma Resection: A Successful Case Study.

    Sciacovelli C · JCEM case reports · 2023

    Case report or series · 2 results

  17. Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes.

    Sood N · JCEM case reports · 2024

    Case report or series · 1 result

  18. Eosinophil-related diseases during treatment with glucagon-like peptide one receptor (GLP-1 RA): a case report and review of the literature.

    Posso-Osorio I · Clinical rheumatology · 2023

    Case report or series · 1 result

  19. Semaglutide-Associated Acute Interstitial Nephritis: A Case Report.

    Borkum M · Kidney medicine · 2022

    Case report or series · 1 result

  20. GLP-1 Receptor Agonists in Diabetes and Obesity: A Case Report and Review of Bowel Obstruction Risks and Management.

    Jones M · Cureus · 2025

    Case report or series · 1 result

  21. The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide.

    Pinheiro MM · Current medical research and opinion · 2024

    Case report or series · 2 results

  22. Semaglutide-Induced Lupus Erythematosus With Multiorgan Involvement.

    Castellanos V · Cureus · 2024

    Case report or series · 8 results

  23. Semaglutide, a Long-Acting GLP-1 Analogue, for the Management of Early-Onset Obesity due to MC4R Defect: A Case Report.

    Gokul PR · Hormone research in paediatrics · 2025

    Case report or series · 7 results

  24. Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study.

    Almutair A · Frontiers in endocrinology · 2024

    Case report or series · 7 results

  25. Semaglutide is effective in type 2 diabetes and obesity with schizophrenia.

    Noda K · Diabetology international · 2022

    Case report or series · 6 results

  26. Semaglutide-induced Hyperemesis Gravidarum.

    Okeke IG · JCEM case reports · 2024

    Case report or series · 2 results

  27. A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12).

    Nakhleh A · Journal of diabetes and its complications · 2023

    Case report or series · 2 results

  28. Meeting the Body Mass Index Requirement for Gender-affirming Surgery Using Antiobesity Medication.

    Taormina JM · JCEM case reports · 2023

    Case report or series · 2 results

  29. Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network.

    Ma J · ACG case reports journal · 2022

    Case report or series · 2 results

  30. GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide).

    Manoharan SVRR · Innovations in clinical neuroscience · 2024

    Case report or series · 1 result

  31. Use of semaglutide in a 54-year-old patient with cocaine abuse and weight loss: a case report.

    Romeo VM · Journal of medical case reports · 2025

    Case report or series · 2 results

  32. Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea.

    Kårhus ML · JCEM case reports · 2023

    Case report or series · 2 results

  33. Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report.

    Sani E · Endocrine, metabolic & immune disorders drug targets · 2022

    Case report or series · 5 results

  34. Unmasking Semaglutide-Induced Gastroparesis: The Dangers of Rapid Dose Escalation in a Diabetic Patient.

    Singhal R · Cureus · 2025

    Case report or series · 4 results

  35. Acute Pancreatitis Likely Due to Semaglutide.

    Hughes K · Cureus · 2024

    Case report or series · 2 results

  36. Late Facial Edema After Lip Filling With Hyaluronic Acid: Possible Association With the Use of Ozempic.

    de Oliveira Ciaramicolo N · The Journal of craniofacial surgery · 2024

    Case report or series · 1 result

  37. Wernicke Encephalopathy Associated With Semaglutide Use.

    Sheth K · Cureus · 2024

    Case report or series · 1 result

  38. Interaction of Semaglutide and Ziprasidone in a Patient With Schizophrenia: A Case Report.

    Hejdak D · Cureus · 2024

    Case report or series · 2 results

  39. Rhabdomyolysis Associated With Semaglutide Therapy: A Case Report.

    Billings SA · Cureus · 2023

    Case report or series · 2 results

  40. Neurological complications associated with rapid weight loss and nutritional deficiencies following GLP-1 agonist use: a case report.

    Zahir A · BMC neurology · 2025

    Case report or series · 5 results

  41. Is Semaglutide Linked to NAION? A Case Report on a Rare Ocular Complication.

    Lešin Gaćina D · Reports (MDPI) · 2025

    Case report or series · 2 results

  42. From Prescription to Predicament: A Case of Semaglutide-Induced Discoid Lupus Erythematosus in an Adult Male Patient.

    Nazzicone K · Cureus · 2025

    Case report or series · 2 results

  43. Severe Hypomagnesemia and Hypocalcemia Linked to Semaglutide in Type 2 Diabetes: A Case Report.

    Davis TME · The American journal of case reports · 2025

    Case report or series · 3 results

  44. Semaglutide-Associated Gastric Pneumatosis.

    Turunen AM · ACG case reports journal · 2025

    Case report or series · 2 results

  45. Semaglutide Inducing Resolution of Proliferative Diabetic Retinopathy: A Case Report.

    Cool D · Case reports in ophthalmological medicine · 2024

    Case report or series · 3 results

  46. Brown Adipose Tissue Mimicking Head and Neck Cancer on PET Scan in a Patient on GLP-1 Drug.

    Harrison DB · The Laryngoscope · 2025

    Case report or series · 2 results

  47. Semaglutide Treatment in a Patient with Extreme Obesity and Massive Lymphedema: A Case Report.

    Nguyen JT · Obesity facts · 2024

    Case report or series · 3 results

  48. Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report.

    Wilcox L · Journal of the American Pharmacists Association : JAPhA · 2024

    Case report or series · 2 results

  49. Delayed Type Hypersensitivity Reaction Induced By Liraglutide With Tolerance to Semaglutide.

    Moreno-Borque R · JCEM case reports · 2024

    Case report or series · 2 results

  50. Discontinuing semaglutide after weight loss: strategy for weight maintenance and a possible new side effect.

    Carris NW · Canadian journal of physiology and pharmacology · 2024

    Case report or series · 8 results

How PepBank reports evidence